• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全局 Rhes 敲除 Q175 亨廷顿病小鼠模型。

Global Rhes knockout in the Q175 Huntington's disease mouse model.

机构信息

Charles River Discovery Services, Kuopio, Finland.

Psychogenics, Paramus, New Jersey, United States of America.

出版信息

PLoS One. 2021 Oct 14;16(10):e0258486. doi: 10.1371/journal.pone.0258486. eCollection 2021.

DOI:10.1371/journal.pone.0258486
PMID:34648564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8516231/
Abstract

Huntington's disease (HD) results from an expansion mutation in the polyglutamine tract in huntingtin. Although huntingtin is ubiquitously expressed in the body, the striatum suffers the most severe pathology. Rhes is a Ras-related small GTP-binding protein highly expressed in the striatum that has been reported to modulate mTOR and sumoylation of mutant huntingtin to alter HD mouse model pathogenesis. Reports have varied on whether Rhes reduction is desirable for HD. Here we characterize multiple behavioral and molecular endpoints in the Q175 HD mouse model with genetic Rhes knockout (KO). Genetic RhesKO in the Q175 female mouse resulted in both subtle attenuation of Q175 phenotypic features, and detrimental effects on other kinematic features. The Q175 females exhibited measurable pathogenic deficits, as measured by MRI, MRS and DARPP32, however, RhesKO had no effect on these readouts. Additionally, RhesKO in Q175 mixed gender mice deficits did not affect mTOR signaling, autophagy or mutant huntingtin levels. We conclude that global RhesKO does not substantially ameliorate or exacerbate HD mouse phenotypes in Q175 mice.

摘要

亨廷顿病(HD)是由亨廷顿蛋白中谷氨酰胺重复扩展突变引起的。尽管亨廷顿蛋白在体内广泛表达,但纹状体受到的病理影响最为严重。Rhes 是一种 Ras 相关的小 GTP 结合蛋白,在纹状体中高度表达,已被报道可调节 mTOR 和突变型亨廷顿蛋白的 sumoylation,从而改变 HD 小鼠模型的发病机制。关于 Rhes 的减少是否对 HD 有益,报告结果不一。在这里,我们在 Q175 HD 小鼠模型中对多种行为和分子终点进行了特征描述,该模型具有遗传 Rhes 敲除(KO)。在 Q175 雌性小鼠中进行遗传 RhesKO 会导致 Q175 表型特征的微妙减弱,以及对其他运动学特征的有害影响。Q175 雌性小鼠表现出可测量的致病缺陷,如 MRI、MRS 和 DARPP32 所示,但 RhesKO 对这些结果没有影响。此外,在 Q175 雌雄混合小鼠中,RhesKO 对 mTOR 信号、自噬或突变型亨廷顿蛋白水平没有影响。我们得出结论,全局 RhesKO 不会显著改善或加重 Q175 小鼠的 HD 表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/650bc119544e/pone.0258486.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/7e9353d08669/pone.0258486.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/46fe2fb1f582/pone.0258486.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/6b92f5a18258/pone.0258486.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/eee031293fdc/pone.0258486.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/07f84d523138/pone.0258486.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/8fb31f2362f7/pone.0258486.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/7730f20ac430/pone.0258486.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/96bcca19d534/pone.0258486.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/51c7899e6953/pone.0258486.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/650bc119544e/pone.0258486.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/7e9353d08669/pone.0258486.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/46fe2fb1f582/pone.0258486.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/6b92f5a18258/pone.0258486.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/eee031293fdc/pone.0258486.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/07f84d523138/pone.0258486.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/8fb31f2362f7/pone.0258486.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/7730f20ac430/pone.0258486.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/96bcca19d534/pone.0258486.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/51c7899e6953/pone.0258486.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef05/8516231/650bc119544e/pone.0258486.g010.jpg

相似文献

1
Global Rhes knockout in the Q175 Huntington's disease mouse model.全局 Rhes 敲除 Q175 亨廷顿病小鼠模型。
PLoS One. 2021 Oct 14;16(10):e0258486. doi: 10.1371/journal.pone.0258486. eCollection 2021.
2
Attenuation of Rhes activity significantly delays the appearance of behavioral symptoms in a mouse model of Huntington's disease.Rhes 活性的衰减显著延缓了亨廷顿病小鼠模型中行为症状的出现。
PLoS One. 2013;8(1):e53606. doi: 10.1371/journal.pone.0053606. Epub 2013 Jan 21.
3
Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.在亨廷顿病小鼠中恢复异常的 mTORC1 活性可改善疾病表型。
Neuron. 2015 Jan 21;85(2):303-15. doi: 10.1016/j.neuron.2014.12.019. Epub 2014 Dec 31.
4
Huntington's disease is a disorder of the corpus striatum: focus on Rhes (Ras homologue enriched in the striatum).亨廷顿病是纹状体的一种疾病:聚焦于 Rhes(富含在纹状体中的 Ras 同源物)。
Neuropharmacology. 2011 Jun;60(7-8):1187-92. doi: 10.1016/j.neuropharm.2010.10.025. Epub 2010 Oct 31.
5
Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease.纹状体丰富的 GTPase Rhes 的异位表达会引起亨廷顿病的小脑变性和共济失调表型。
Neurobiol Dis. 2015 Oct;82:66-77. doi: 10.1016/j.nbd.2015.05.011. Epub 2015 Jun 3.
6
Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy.Rhes,一种纹状体选择性蛋白,与亨廷顿病有关,它与 beclin-1 结合并激活自噬。
J Biol Chem. 2014 Feb 7;289(6):3547-54. doi: 10.1074/jbc.M113.536912. Epub 2013 Dec 9.
7
Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy.纹状体富集 Ras 同源物的生物信息学分析,亨廷顿病治疗的一个潜在靶点。
Int J Mol Med. 2019 Dec;44(6):2223-2233. doi: 10.3892/ijmm.2019.4373. Epub 2019 Oct 15.
8
The role of Rhes, Ras homolog enriched in striatum, in neurodegenerative processes.Ras 同源物富集在纹状体中的 Rhes 在神经退行性过程中的作用。
Exp Cell Res. 2013 Sep 10;319(15):2310-5. doi: 10.1016/j.yexcr.2013.03.033. Epub 2013 Apr 10.
9
TYROBP/DAP12 knockout in Huntington's disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration.亨廷顿病 Q175 小鼠的 TYROBP/DAP12 基因敲除细胞自主降低小胶质细胞中与疾病相关基因的表达,而非细胞自主减轻星形胶质细胞增生和运动功能恶化。
J Neuroinflammation. 2024 Mar 8;21(1):66. doi: 10.1186/s12974-024-03052-4.
10
The p75 neurotrophin receptor augments survival signaling in the striatum of pre-symptomatic Q175(WT/HD) mice.p75神经营养因子受体增强了症状前Q175(野生型/亨廷顿舞蹈症)小鼠纹状体中的存活信号。
Neuroscience. 2016 Jun 2;324:297-306. doi: 10.1016/j.neuroscience.2016.02.069. Epub 2016 Mar 3.

引用本文的文献

1
mTOR inhibition in Q175 Huntington's disease model mice facilitates neuronal autophagy and mutant huntingtin clearance.在Q175亨廷顿舞蹈病模型小鼠中抑制mTOR可促进神经元自噬及突变型亨廷顿蛋白的清除。
Elife. 2025 May 20;14:RP104979. doi: 10.7554/eLife.104979.
2
Magnetic Resonance Imaging to Detect Structural Brain Changes in Huntington's Disease: A Review of Data from Mouse Models.磁共振成像检测亨廷顿病的结构性脑变化:来自小鼠模型的数据综述。
J Huntingtons Dis. 2024;13(3):279-299. doi: 10.3233/JHD-240045.
3
Rhes depletion promotes striatal accumulation and aggregation of mutant huntingtin in a presymptomatic HD mouse model.

本文引用的文献

1
Rhes, a striatal enriched protein, regulates post-translational small-ubiquitin-like-modifier (SUMO) modification of nuclear proteins and alters gene expression.Rhes,一种纹状体丰富的蛋白,调节核蛋白的翻译后小泛素样修饰物(SUMO)修饰,并改变基因表达。
Cell Mol Life Sci. 2024 Apr 8;81(1):169. doi: 10.1007/s00018-024-05181-8.
2
Rapid and robust patterns of spontaneous locomotor deficits in mouse models of Huntington's disease.亨廷顿病小鼠模型中自发性运动缺陷的快速和显著模式。
PLoS One. 2020 Dec 28;15(12):e0243052. doi: 10.1371/journal.pone.0243052. eCollection 2020.
3
Progression of basal ganglia pathology in heterozygous Q175 knock-in Huntington's disease mice.
在症状前亨廷顿舞蹈症小鼠模型中,去除恒河猴因子促进了突变型亨廷顿蛋白在纹状体中的积累和聚集。
Front Aging Neurosci. 2023 Aug 10;15:1237018. doi: 10.3389/fnagi.2023.1237018. eCollection 2023.
4
Role of SUMOylation in Neurodegenerative Diseases.SUMOylation 在神经退行性疾病中的作用。
Cells. 2022 Oct 27;11(21):3395. doi: 10.3390/cells11213395.
杂合性 Q175 敲入亨廷顿病小鼠基底节病理进展。
J Comp Neurol. 2021 May 1;529(7):1327-1371. doi: 10.1002/cne.25023. Epub 2020 Sep 20.
4
Loss of Hap1 selectively promotes striatal degeneration in Huntington disease mice.Hap1 缺失选择性促进亨廷顿病小鼠纹状体变性。
Proc Natl Acad Sci U S A. 2020 Aug 18;117(33):20265-20273. doi: 10.1073/pnas.2002283117. Epub 2020 Aug 3.
5
RasGRP1 is a causal factor in the development of l-DOPA-induced dyskinesia in Parkinson's disease.RasGRP1 是帕金森病中 l-DOPA 诱导运动障碍发展的一个因果因素。
Sci Adv. 2020 May 1;6(18):eaaz7001. doi: 10.1126/sciadv.aaz7001. eCollection 2020 May.
6
Rhes, a striatal-enriched protein, promotes mitophagy via Nix.Rhes,一种纹状体丰富的蛋白,通过 Nix 促进线粒体自噬。
Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23760-23771. doi: 10.1073/pnas.1912868116. Epub 2019 Nov 1.
7
IKKβ slows Huntington's disease progression in R6/1 mice.IKKβ 可减缓 R6/1 小鼠亨廷顿病的进展。
Proc Natl Acad Sci U S A. 2019 May 28;116(22):10952-10961. doi: 10.1073/pnas.1814246116. Epub 2019 May 14.
8
Modulation of mTOR and CREB pathways following mGluR5 blockade contribute to improved Huntington's pathology in zQ175 mice.mGluR5 阻断后 mTOR 和 CREB 通路的调节有助于改善 zQ175 小鼠的亨廷顿病病理。
Mol Brain. 2019 Apr 8;12(1):35. doi: 10.1186/s13041-019-0456-1.
9
Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age.缺乏 RhES 会增加 MDMA 引起的神经炎症和多巴胺神经元变性:性别和年龄的作用。
Int J Mol Sci. 2019 Mar 28;20(7):1556. doi: 10.3390/ijms20071556.
10
Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age.视性别和年龄而定,Rhes可对抗多巴胺能神经元变性和神经炎症。
Front Aging Neurosci. 2018 May 31;10:163. doi: 10.3389/fnagi.2018.00163. eCollection 2018.